Baylor College of Medicine and National Urea Cycle Disorders Foundation Collaborate on Preclinical Research



Baylor College of Medicine and the National Urea Cycle Disorders Foundation (NUCDF) have together established the CureUCD Center for Preclinical Therapeutic Discovery to advance the understanding, treatment, and cure of urea cycle disorders, which are caused by a mutation resulting in a deficiency of one of the six enzymes in the urea cycle.

The urea cycle is responsible for detoxifying ammonia, a by-product of protein metabolism, in the bloodstream. In urea cycle disorders, ammonia builds up to toxic levels that, without intervention, damage the brain and can result in coma and death.

Supported by NUCDF, which serves patients and families affected by these conditions, the CureUCD Center will engage technology and drug companies in early stage testing and validation studies of new small molecules, nucleic acids, and cell and gene therapies for these disorders.

Recommended Reading

Rare Disease Community Prepares for Worldwide Observance of Rare Disease Day
MDedge Cardiology
Omnibus Spending Bill Includes Provisions Important to the Rare Disease Community
MDedge Cardiology
FDA Invites Patient Organizations to Organize Public Meetings to Enhance Awareness of Their Needs
MDedge Cardiology
NIH Releases Its Strategic Plan
MDedge Cardiology
NORD Publishes Physician Guides to PNH and aHUS
MDedge Cardiology